Insulin Pumps
Insulet Reports Fourth Quarter and Full Year 2012 Results
February 28, 2013 (Insulet Corporation) — Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced financial results for the fourth quarter and full year ended December 31, 2012.
Fourth Quarter Results
Fourth quarter 2012 revenue increased 23% to $57.8 million, compared to $47.2 million in the fourth quarter of 2011. Gross profit for the fourth quarter of 2012 improved by 26% to $25.3 million, as compar
Continue reading "Insulet Reports Fourth Quarter and Full Year 2012 Results"
Email this National Wildlife Federation: Time Outdoors Improves Nation’s Health
July 29, 2009 (Newswise) - The Centers for Disease Control and Prevention (CDC) this week held an inaugural conference on obesity prevention and control. The CDCs Division of Nutrition, Physical Activity, and Obesity convened in Washington, D.C. to chart ways to improve access to healthy places, discuss opportunities for obesity prevention, and plan physical education standards in schools through federal policy.Obesity is a risk factor for a number of chronic diseases, including diabetes, heart problems, osteoarthriti
Continue reading "National Wildlife Federation: Time Outdoors Improves Nation’s Health"
Email this Elron Group Company Medingo Receives Formal FDA Clearance to Market Its Insulin Micropump in the United States
July 28, 2009 (BusinessWire) - Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) announced today, that further to it previous announcement on July 28, 2009, Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC Rafael Development Corporation Ltd., has received formal clearance from the Food and Drug Administration ("FDA"), to market its Solo MicroPump Insulin Delivery System in the United States.Medingo intends to introduce the Solo
Email this Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control – Call for Systemic Changes in Hospitals Nationwide
May 8, 2009 (AACE) - New recommendations released today by a consensus group of the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) are calling for major changes in the way health care professionals treat hospitalized patients with high blood glucose (sugar) levels. The authors recommend revised glucose targets of 140-180 mg/dL in the ICU setting, and between 100-180 mg/dL for most patients admitted to general medical-surgical wards.The recommendations,
Email this Disetronic Medical Systems Inc. (a Member of the Roche Group) Announces a Recall (Field Corrective Action) of the ACCU-CHEK® Sp
April 30, 2009 (FDA.gov) - This notification applies to all ACCU-CHEK Spirit insulin pumps with serial numbers from SN02119552 through SN10006093 (range of SN shipped to the US). Pumps with serial numbers including and above SN10006094 are not affected and no action is required by users of these pumps.Disetronic Medical Systems Inc. announced today that it is notifying its customers, distributors and healthcare professionals about a potential defect in the up and/or down buttons of some ACCU-
Email this 
You are subscribed!
You are subscribed!
You are subscribed!
dLife Weekly Poll
How much do you know about the health risks associated with diabetes, such as heart disease and stroke?
